Incentive Stock Option AgreementIncentive Stock Option Agreement • April 26th, 2024 • Nuvation Bio Inc. • Pharmaceutical preparations • Delaware
This Incentive Stock Option Agreement (this “Agreement”) is made and entered into as of [__] by and between AnBio Therapeutics Ltd., an exempted company with limited liability organized and existing under the laws of Cayman Islands (the “Company”) and [__] (the “Participant”).
Restricted Stock Unit Agreement (New Hire Grant)Restricted Stock Unit Agreement • April 26th, 2024 • Nuvation Bio Inc. • Pharmaceutical preparations • Delaware
This Restricted Stock Unit Agreement (this “Agreement”) is made and entered into as of March 24, 2024 (the “Grant Date”) by and between AnHeart Therapeutics Ltd. (f/k/a AnBio Therapeutics Ltd.), an exempted company with limited liability organized and existing under the laws of the Cayman Islands (the “Company”), and ______________, (the “Participant”). This Agreement is being entered into pursuant to the AnBio Therapeutics Ltd 2021 Equity Incentive Plan (the “Plan”). Capitalized terms used in this Agreement but not defined herein will have the meaning ascribed to them in the Plan.
April 30, 2022 Dongfang Liu, MD, PhD 12925 Northeast 100th Lane Kirkland, WA 98033 Re: Offer Letter for Chief Medical Officer Dear Dongfang:Nuvation Bio Inc. • April 26th, 2024 • Pharmaceutical preparations
Nuvation Bio Inc. (the “Company”) is pleased to offer you the position of Chief Medical Officer on the terms set forth in this letter agreement (the “Agreement”).
March 24, 2024Merger Agreement • April 26th, 2024 • Nuvation Bio Inc. • Pharmaceutical preparations
This Agreement records certain agreements between you and Dr. David Hung (“Dr. Hung”), the record and beneficial holder of 100% of the issued and outstanding shares of Parent Class B Common Stock (the “Class B Shares”), regarding certain matters with respect to the post-Closing board of directors of Parent (the “Board”). Capitalized terms not otherwise defined herein shall bear the meaning given to them in the Merger Agreement.
EMPLOYMENT AGREEMENTEmployment Agreement • April 26th, 2024 • Nuvation Bio Inc. • Pharmaceutical preparations
June 28, 2019 Gary Hattersley, Ph.D. 22 Brandymeade Circle Stowe, MA 01775 Re: Offer Letter for Chief Scientific Officer Dear Gary:Nuvation Bio Inc. • April 26th, 2024 • Pharmaceutical preparations
Nuvation Bio Inc. (the "Company") is pleased to offer you the position of Chief Scientific Officer on the terms set forth in this letter agreement (the "Agreement").
